Neumora Therapeutics Inc.’s stock tumbled 80% Thursday, after the clinical-stage biotech said a late-stage trial of a ...

During both studies, scores on the rating scale for schizophrenia decreased ... How Was Caplyta Studied for the Treatment of Bipolar Depression? Two clinical studies evaluated the safety and ...

AbbVie has reported new phase 3 data for its schizophrenia and bipolar disorder therapy ... improvement on the Montgomery-Åsberg Depression Rating Scale (MADRS) compared to placebo in treatment ...